Venture
A venture is, by nature, a risky business undertaking with an uncertain outcome.
We are building a Health Innovation and Venture Building Platform at FN Olomouc — the simplest route for innovators into clinical practice and health data, and from research to real-world impact.
And we want to build it with you.
There is “Ventures” in our name. That does not make us an investment fund. It describes how we work.
A venture is, by nature, a risky business undertaking with an uncertain outcome.
Venture building is a systematic process that tests a new business idea step by step, with small investments and clear go / pivot / stop decisions. Serious capital comes only once there is evidence.
Co-design phase · Open now
To create a system that truly fits the real needs of everyone who will work with it, we need to know as much as possible about you — your plans, your needs, and the obstacles you face. Your input will directly shape what we build first.
Who you are, what you are working on, and what you would need from a hospital-based innovation platform.
We confirm that we have received your input and work with it responsibly as we design the concept.
We will get in touch once the service designed for you is actually ready.
Already have a concrete project? The questionnaire will lead you on to our pitch step.
We are building Tafelberg Ventures as the innovation and venture-building platform of FN Olomouc — bridging clinical excellence with entrepreneurial capital.
Our aim is to turn medical research, biomedical expertise, and hospital data into real-world health solutions that improve patients’ lives, and to support clinicians, researchers, and innovators in developing ideas with genuine patient impact — through spin-offs, commercial partnerships, and open innovation.
Access to the clinical environment and to health data is the hardest step for every health innovation. That is exactly where we want to make the biggest difference.
From 1 January 2027, the new Czech Act on Research, Development, Innovation and Knowledge Transfer (No. 328/2025 Coll.) makes it considerably easier for public research organisations — university hospitals included — to bring their results to market. We want FN Olomouc to be ready on day one.
The summit where all nine meet — one platform connecting clinical practice, research, capital, and industry. We are building it now, together with those it is meant to serve.
Driving innovation through cutting-edge MedTech solutions and digital health infrastructure built for real clinical environments.
Harnessing AI to transform healthcare data into actionable clinical and commercial insights that accelerate diagnosis, treatment, and research.
Building the healthcare platform of tomorrow — proactive, personalized, predictive, and grounded in the realities of modern medicine.
Empowering founders and innovators with hospital-grade validation, clinical access, and venture support to bring ideas to market.
Advancing science and business at the frontier of healthy aging, precision medicine, and evidence-backed longevity interventions.
Grounded in world-class biomedical research and clinical expertise at one of the Czech Republic’s top teaching hospitals.
Every innovation validated against rigorous clinical evidence and real-world outcomes — not just theory or prototype-stage assumptions.
Deep integration with academic and applied research programs to accelerate translational medicine and bring discoveries to patients faster.
Scaling healthcare ventures from concept to commercialization with strategic capital connections, partnership networks, and venture-building expertise.
Beyond the acronym, Tafelberg Ventures is equally focused on Medicine, Prevention and Startups — integrating clinical practice, proactive health innovation, and entrepreneurial venture-building into one cohesive platform.
This is the platform we are setting out to build: Tafelberg Ventures at the intersection of clinical excellence, capital flows, research infrastructure, and commercial partnerships — a healthcare innovation flywheel.
Platform services
TafelVentVenture Building
TafelVentInfrastructure
Labs / Testbeds
Platform players
FN OlomoucClinical Settings
MarketCompanies &
Commercial Partners
FN OlomoucData & ICT
PublicState / Public
Stakeholders
CapitalVenture / Private Capital
CapitalGrants & Public Funds
Platform
incubation
Portfolio project / venture
Portfolio project / venture
Portfolio project / venture
Portfolio project / venture
FN projects
Startups / SMEs
External projects
FN projects
Startups / SMEs
External projects
Whether you come from the lab, the clinic, or the boardroom — we are designing the platform around what you need. This is what we plan to offer, and your input will decide what comes first.
Clinicians & Researchers
You should not have to become an entrepreneur. You need a partner who can translate your clinical insight into a scalable solution. We are building the structure, legal setup, business mentoring, and capital connections for this — so you can stay focused on what you do best.
“My job is medicine, not business” — we hear that. And we agree.
Startups & Innovators
Clinical validation is the hardest and most valuable step in MedTech. Through TafelVent Gate we want to open FN Olomouc for structured pilots, access to anonymised data within legal frameworks, and co-development with clinicians and researchers.
“We have the product — we need clinical proof.”
Investors & Capital Partners
Projects in our future pipeline will be assessed by clinicians, tested against real patient needs, and checked for commercial viability. We want to connect venture funds, family offices, and angel investors with innovations that have a real hospital behind them.
“Where do I find validated MedTech opportunities in Central Europe?”
Industry & Corporate Partners
We want to give Pharma, MedTech, Digital Health, and Life Sciences companies a structured gateway into FN Olomouc, one of the Czech Republic’s leading university hospitals — to pilot technologies, run studies, or co-develop solutions with clinical teams under clear rules.
“We need a real hospital partner for our innovation pipeline.”
From a first idea to a scaled health innovation — the programmes we are designing, stage by stage. Their final shape will follow what you tell us.
Identifying and evaluating innovations with genuine clinical potential — feasibility, patient relevance, and commercial fit, assessed together with your team.
Open to all
Structured pilots within FN Olomouc departments. Real data, real clinical settings, real feedback. This is where ideas become evidence.
Cohort-based
Company setup, IP structuring, product development, team building, and first capital. We want to provide the scaffolding — you build the company.
Selected projects
Growth financing, market entry, regulatory approval, and international expansion — opening doors to investors, industry partners, and health markets.
Portfolio ventures
Between every stage: a decision based on evidence
GoPivotStop
We are building the platform together with investors and innovators who share our goal — and we are looking for more.
The needs questionnaire is the best way to help shape the platform. For anything else — press, partnerships, or a simple question — write to us here.